Caricamento...
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
Liquid biopsy tests have become an integral part of the molecular diagnosis of patients with non-small cell lung cancer (NSCLC). We describe a new test panel that uses very low input (20 ng) of cell-free nucleic acids extracted from human plasma, which is designed to yield results in less than 72 h....
Salvato in:
| Pubblicato in: | Diagnostics (Basel) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7912015/ https://ncbi.nlm.nih.gov/pubmed/33494470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11020155 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|